Mihalopoulos, C., Baxter, A. J., Whiteford, H., & Vos, T. (2014). The Cost-effectiveness of Treatments for Anxiety Disorders. In P. Emmelkamp & T. Ehring (Eds.), The Wiley Handbook of Anxiety Disorders. Chichester, UK: John Wiley & Sons, Ltd....
Background: Anxiety disorders are highly prevalent mental disorders that constitute a major burden on patients and society. As a consequence, economic evaluations of the interventions have become increasingly important. However, no recent overview of these economic evaluations is currently available and th...
BACKGROUND: Individuals with anxiety disorders often do not receive an accurate diagnosis or adequate treatment in primary care. AIMS: To analyse the cost-effectiveness of an optimised care model for people with anxiety disorders in primary care. METHOD: In a cluster randomised controlled trial, 46...
This study used decision modelling to compare the cost-effectiveness of venlafaxine XL (Efexor XL) to that of diazepam to treat non-depressed patients suffering from generalised anxiety disorder (GAD), from the perspective of the United Kingdom’s National Health Service (NHS). Starting treatment ...
BACKGROUND: The present paper describes a component of a large population cost-effectiveness study that aimed to identify the averted burden and economic efficiency of current and optimal treatment for the major mental disorders. This paper reports on the findings for the anxiety disorders (panic dis...
In this study we evaluate the effectiveness and cost-effectiveness of a self-management intervention for patients with chronic and treatment resistant anxiety or depressive disorders in specialized outpatient mental health care. The results of this study may provide a first 'proof-of-concept' in this...
Identifying and supporting young children who are at risk of developing anxiety disorders would benefit children, families, and wider society. Elevated anxiety symptoms, inhibited temperament, and high parental anxiety are established risk factors for la
in terms of cost-effectiveness and cost-utility, a brief, transdiagnostic CBT in two different formats, individual and group, with the treatment ordinarily administered in primary care (treatment as usual [TAU]) for mild to moderate EDs (i.e., depressive, anxiety, and somatoform disorders). We...
ContextDepression is a leading cause of functional impairment in elderly individuals and is associated with high medical costs, but there are large gaps
A significant proportion of the general population suffers from anxiety disorders, often with comorbid psychiatric conditions. Internet-delivered cognitive behavior therapy (ICBT) has been found to be a potent treatment for patients with specific psychiatric conditions. The aim of this trial was to inve...